Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Pardubice – page 2

160 clinical trials in Pardubice, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Pardubice at a glance
160
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

160 trials in Pardubice

Open in trial search

A study of the safety and efficacy of AC01 in patients with heart failure with reduced ejection fraction

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AnaCardio AB

Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Fesoterodine
  • Sponsor:Maplight Therapeutics Inc.

Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Pfizer Inc.

Obesity+2

Recruiting

Study of the efficacy and safety of Eloralintide in adults with knee osteoarthritis and overweight or obesity

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 sodium
  • Sponsor:Eli Lilly & Co.

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

Crohn's disease

Recruiting

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Icotrokinra
  • Sponsor:Janssen Cilag International

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Icotrokinra
  • Sponsor:Janssen Cilag International

A Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Fesoterodine
  • Sponsor:Maplight Therapeutics Inc.

Study comparing remibrutinib and ocrelizumab in patients with relapsing multiple sclerosis who switch from ocrelizumab treatment

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab
  • Sponsor:Novartis Pharma AG

Study of oral BI 1815368 compared to placebo in patients with diabetic macular edema over 48 weeks of treatment

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim International GmbH

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Pardubice

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical trials focusing on vaccine development for preventable diseases, including studies of new chickenpox vaccines and advanced meningococcal vaccines for infants and children.

  • Varicella immunization
  • Meningococcal disease prevention
  • Pediatric vaccine safety

Research emphasizes immune response monitoring and safety assessment in young populations.

02 Autoimmune Conditions

Innovative research targeting various autoimmune disorders, with studies evaluating new treatments for psoriatic arthritis and multiple sclerosis.

  • Plaque psoriasis treatments
  • MS therapy advancement
  • Immune system modulation

Trials focus on developing targeted therapies for chronic inflammatory conditions.

03 Neurological Disorders

Studies investigating new therapeutic approaches for Parkinson's Disease and other neurological conditions, with emphasis on improving patient outcomes.

  • Movement disorders
  • Neurodegenerative diseases
  • Symptom management

Research aims to enhance treatment options and quality of life for patients.

04 Oncology Research

Advanced clinical trials focusing on prostate cancer treatment, particularly addressing metastatic castration-resistant cases.

  • Targeted cancer therapies
  • Hormone-resistant cancers
  • Combination treatments

Studies emphasize novel therapeutic approaches for advanced-stage cancers.

05 Musculoskeletal Conditions

Research investigating treatments for osteoarthritis and joint disorders, including innovative therapies for knee-specific conditions.

  • Pain management
  • Joint function improvement
  • Inflammatory conditions

Focus on developing both systemic and topical treatments for joint diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.